NurExone Biologic Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 0.705 million compared to USD 2.32 million a year ago. Basic loss per share from continuing operations was USD 0.016 compared to USD 0.08 a year ago.
NurExone Biologic Inc. Toronto S.E.
Equities
ENER
CA29278Q1063
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |